Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Although the revenue and EPS for First Citizens (FCNCA) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

While the top- and bottom-line numbers for Booz Allen (BAH) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Intel Corporation remains a Hold as recent stock price gains are not justified by fundamentals or near-term prospects. I trimmed again. Q4 2025 performance exceeded guidance, but revenue and gross margins declined year-over-year, and INTC annual revenue fell versus 2024. INTC management's Q1 2026 guidance is modest, with EPS expected at $0 and gross margin shrinking to 34.5%, reflecting acute internal supply constraints.

NEW YORK, NY / ACCESS Newswire / January 23, 2026 / Those new to SMX (NASDAQ:SMX) may be focused primarily on its impressive 2025 rally. That's fine from an investor perspective.

Southern First Bancshares (SFST) remains a Buy, supported by robust Q4 2025 results and a favorable regional economic backdrop. SFST delivered $1.21 EPS in Q4, outpacing estimates, and achieved 94.8% full-year EPS growth, driven by revenue gains and cost control. The stock trades at 1.31x tangible book value, well below recent peer M&A multiples, highlighting significant potential upside in a buyout scenario.

SAN FRANCISCO, Jan. 23, 2026 /PRNewswire/ -- National shareholder rights firm Hagens Berman is notifying Ardent Health, Inc. (NYSE: ARDT) investors that a securities class action lawsuit has been filed against the company and certain of its executives following the company's disastrous Q3 2025 financial results. Hagens Berman is investigating the alleged claims that Ardent misled investors about its revenue recognition systems and the adequacy of its professional liability reserves.

Investors need to pay close attention to PLNT stock based on the movements in the options market lately.

This is a developing story.

If you worked for decades, there's a good chance you'll be eligible for Social Security benefits once you retire.